SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 58 filers reported holding SYNERON MEDICAL LTD in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $8,000 | -11.1% | 738 | -15.8% | 0.00% | – |
Q1 2017 | $9,000 | +50.0% | 876 | +19.8% | 0.00% | – |
Q4 2016 | $6,000 | +50.0% | 731 | +23.3% | 0.00% | – |
Q3 2016 | $4,000 | -20.0% | 593 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | +25.0% | 593 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | -20.0% | 593 | 0.0% | 0.00% | – |
Q4 2015 | $5,000 | +25.0% | 593 | 0.0% | 0.00% | – |
Q3 2015 | $4,000 | +33.3% | 593 | +96.4% | 0.00% | – |
Q2 2015 | $3,000 | -62.5% | 302 | -50.0% | 0.00% | – |
Q1 2015 | $8,000 | +166.7% | 604 | +100.0% | 0.00% | – |
Q4 2014 | $3,000 | -88.5% | 302 | -88.4% | 0.00% | – |
Q3 2014 | $26,000 | +766.7% | 2,602 | +761.6% | 0.00% | – |
Q2 2014 | $3,000 | -40.0% | 302 | -20.9% | 0.00% | – |
Q1 2014 | $5,000 | -16.7% | 382 | -20.7% | 0.00% | – |
Q4 2013 | $6,000 | -89.3% | 482 | -92.6% | 0.00% | – |
Q3 2013 | $56,000 | 0.0% | 6,529 | +0.0% | 0.00% | – |
Q2 2013 | $56,000 | – | 6,528 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Senvest Management, LLC | 2,988,261 | $25,759,000 | 2.86% |
NORTH TIDE CAPITAL, LLC | 2,150,000 | $18,533,000 | 1.94% |
HOURGLASS CAPITAL, LLC | 838,900 | $7,231,000 | 1.26% |
Baupost Group | 4,000,000 | $34,480,000 | 0.98% |
DAFNA Capital Management LLC | 90,947 | $784,000 | 0.86% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 573,108 | $4,940,000 | 0.77% |
Visium Asset Management, LP | 3,405,000 | $29,351,000 | 0.67% |
PERRITT CAPITAL MANAGEMENT INC | 380,000 | $3,276,000 | 0.64% |
Leonard Capital Management, Inc. | 112,109 | $966,000 | 0.38% |
BRANDES INVESTMENT PARTNERS, LP | 1,765,018 | $15,214,000 | 0.20% |